Taiantang new drug "shezhishenhuang ointment" officially approved for market

Taiantang announced in the evening of November 16 that recently, the company received the approval document for supplementary drug application (approval document No.: 2015b01581) issued by the State Food and drug administration The new drug "shezhishenhuang ointment" researched and developed by the company was approved by the drug approval document No (gyzz20153056), and the product was officially approved for production and marketing Announcement of Guangdong taiantang Pharmaceutical Co., Ltd on obtaining the national approval number of new drugs the company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions Guangdong taiantang Pharmaceutical Co., Ltd (hereinafter referred to as "the company") received the new drug certificate and drug registration approval document of "snake fat shenhuang ointment" issued by the State Food and Drug Administration in January 2015 (see company announcement: 2015-013 for details) Recently, the company received the approval document of drug supplement application (approval document No.: 2015b01581) issued by the State Food and drug administration ）The new drug "shezhishenhuang ointment" researched and developed by the company has obtained the drug approval number (gyzz z20153056), and the product has been officially approved for production and marketing Shezhishenhuang ointment is a new Chinese medicine Its main ingredients are snake fat, red ginseng, Sophora flavescens, wattle skin, aloe, etc it has the efficacy of killing insects and relieving itching, clearing away heat and drying dampness It is clinically used for the treatment of subacute eczema, tinea pedis and cruris, damp heat accumulation syndrome and other skin diseases The drug obtained the drug approval number and was approved for production and marketing, which further enriched and optimized the company's skin medicine products, further established the company's dominant position in the Chinese medicine skin medicine market segment, and will have a positive impact on the company's product sales and business performance It is hereby announced that the board of directors of Guangdong taiantang Pharmaceutical Co., Ltd on November 17, 2015, Guangdong taiantang Pharmaceutical Co., Ltd is a professional pharmaceutical enterprise with traditional Chinese medicine skin medicine and special Chinese patent medicine as its leading products, integrating scientific research, production and sales It has three subsidiaries: Shanghai jinpipao Pharmaceutical Co., Ltd., Guangdong Pipao Pharmaceutical Co., Ltd and Shanghai taiantang Pharmaceutical Co., Ltd., and two research and development institutions including Guangdong traditional Chinese medicine skin medicine engineering technology research and development center and taiantang postdoctoral workstation   At all times and in all countries, the company has inherited the tradition, relying on the essence of Kirin's ancestral Chinese medicine, Wan Shi's medicine and jade well treasure, and gradually developed and produced products of "anti inflammatory ringworm wet ointment", "Qilin pill", "Xinbao pill" and "Qubi Shu Wan" The company has created new products, has won the essence of ancient and modern medicine, and integrated the latest sophisticated technology of modern medicine, and boldly explored The new development path of modernization of traditional Chinese medicine is to build a three-dimensional network of research and development of Peabody, which has made a number of technological breakthroughs in the modernization of traditional Chinese medicine It has become a leading enterprise in the market of Chinese medicine dermatosis